Show Notes
The three-year transition period for the new Medical Device Regulation will end on 26 May 2020, and the new In Vitro Diagnostic Regulation will come into force in 2022. These new pieces of legislation bring changes to one of the pillars of the medical technology sector: the CE marking process. In this episode, we speak to Oliver Bisazza about what this process is, how it changes and what the medtech industry has to say about it.
More from MedTech ON AIR
In early October 2026, the European Commission adopted its first decision to select two medical devices for joint clinical assessment under the EU Health Technology Assessment (#HTA).
How can Europe ensure that groundbreaking health innovations actually reach patients?
Between sessions at the MedTech Forum 2026, we sat down with Flora Giorgio, Head of Unit D3Medical Devices at the European Commission's DG SANTE. In this conversation, we unpack some of the most consequential files in medtech policy right now: from the revision of the Medical Devices Regulation and the In Vitro Diagnostics Regulation, to EUDAMED implementation and the European Commission’s breakthrough pilot.
From our booth at the MedTech Forum 2026, we sat down with Prof. Marc Peeters, Professor of Oncology at the University of Antwerp and board member of AZ Maria Middelares and Ziekenhuis Geel. We discussed today’s challenges and opportunities in medtech, and AI emerged as a clear leitmotif throughout the conversation. Timely, as discussions on the interplay between the AI Act and the MDR/IVDR revision continue to unfold.
Health drives our lives, from our personal well-being to the health of our planet and economy. On the road to UN Climate Change Conference COP30 in Belém (Brazil), taking place from 10-21 November 2025, we shine a critical spotlight on harnessing medical technology innovation for healthcare decarbonisation.